Sobi Appoints Senior Vice President CQCO
This article was originally published in Scrip
Sobi has appointed Lars Dreiøe senior vice president of chief quality & compliance officer (CQCO). Dreiøe has over 20 years' experience in the biotech and pharmaceutical industry and was previously at ALK in Denmark, where he was international head of quality. He will join Sobi on Jan. 18, 2016.
You may also be interested in...
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.